Mark H. Yudin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mark H. Yudin has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Catherine Bsc Moravac
The authors thank Rosane Nisenbaum for assistance with statistical analysis and the nurses of the Women’s Health Care Centre at St. Michael’s Hospital for their assistance with enrollment
1 shared publicationDonna M. Steele
1 shared publication- Heather Shapiro
Mount Sinai Centre for Fertility and Reproductive Health, University of Toronto
1 shared publication Kevin A. Gough
1 shared publicationMichael D. Sgro
1 shared publication- Mona Loutfy
University of Toronto
1 shared publication
Latest Publications
- Open Access
- 12 May 2010
- Published by Springer Nature in Reproductive Health
- Vol. 7 (1) , 7
Access to infertility services in Canada for HIV-positive individuals and couples: a cross-sectional study
Family and pregnancy planning issues are important among human immunodeficiency virus (HIV)-positive individuals and couples. However, access to fertility services may be limited for this population. The objective of this study was to estimate the types of services available in fertility clinics in Canada for these individuals.
- 12 May 2010
- Published by Springer Nature in Reproductive Health
- Vol. 7 (1) , 7
Open AccessAccess to infertility services in Canada for HIV-positive individuals and couples: a cross-sectional study
Family and pregnancy planning issues are important among human immunodeficiency virus (HIV)-positive individuals and couples. However, access to fertility services may be limited for this population. The objective of this study was to estimate the types of services available in fertility clinics in Canada for these individuals.
- Open Access
- 1 January 2008
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2008, 1-4
Progressive Hypertrophic Genital Herpes in an HIV-Infected Woman despite Immune Recovery on Antiretroviral Therapy
Most HIV-infected individuals are coinfected byHerpes simplex virustype 2 (HSV-2). HSV-2 reactivates more frequently in HIV-coinfected individuals with advanced immunosuppression, and may have very unusual clinical presentations, including hypertrophic genital lesions. We report the case of a progressive, hypertrophic HSV-2 lesion in an HIV-coinfected woman, despite near-complete immune restoration on antiretroviral therapy for up to three years. In this case, there was prompt response to topical imiquimod. The immunopathogenesis and clinical presentation of HSV-2 disease in HIV-coinfected individuals are reviewed, with a focus on potential mechanisms for persistent disease despite apparent immune reconstitution. HIV-infected individuals and their care providers should be aware that HSV-2 may cause atypical disease even in the context of near-comlpete immune reconstitution on HAART.
- 1 January 2008
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2008, 1-4
Open AccessProgressive Hypertrophic Genital Herpes in an HIV-Infected Woman despite Immune Recovery on Antiretroviral Therapy
Most HIV-infected individuals are coinfected byHerpes simplex virustype 2 (HSV-2). HSV-2 reactivates more frequently in HIV-coinfected individuals with advanced immunosuppression, and may have very unusual clinical presentations, including hypertrophic genital lesions. We report the case of a progressive, hypertrophic HSV-2 lesion in an HIV-coinfected woman, despite near-complete immune restoration on antiretroviral therapy for up to three years. In this case, there was prompt response to topical imiquimod. The immunopathogenesis and clinical presentation of HSV-2 disease in HIV-coinfected individuals are reviewed, with a focus on potential mechanisms for persistent disease despite apparent immune reconstitution. HIV-infected individuals and their care providers should be aware that HSV-2 may cause atypical disease even in the context of near-comlpete immune reconstitution on HAART.
- 1 July 2007
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 110 (1) , 81-86
Influence of an “Opt-Out” Test Strategy and Patient Factors on Human Immunodeficiency Virus Screening in Pregnancy
OBJECTIVE: To estimate both human immunodeficiency virus (HIV) testing acceptance rates in pregnancy using an opt-out policy and patient characteristics influencing acceptance. METHODS: At the first prenatal visit, HIV testing was offered using an opt-out approach. Reasons for refusing testing were explored. Demographic information was collected on all study subjects. RESULTS: In the prospective portion of the study, 1,140 of 1,233 women (92.5%) accepted testing. Race was predictive of accepting HIV testing, with Asian women significantly less likely (odds ratio [OR] 0.4; 95% confidence interval [CI] 0.3–0.6; P<.001) and Hispanic women significantly more likely (OR 6.9; 95% CI 2.2–22.0; P=.001) to be tested. Although English as a first language, country of birth, and insurance status were not significantly associated with acceptance, women who were fluent in English were more likely to be tested (OR 2.0; 95% CI 1.2–3.3; P=.01). Our testing rates were significantly higher than the provincial average. CONCLUSION: Using an opt-out strategy, HIV testing rates in our clinic were significantly higher than the provincial average. Rates were influenced by race and fluency in English. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov , www.clinicaltrials.gov , NCT00393302 LEVEL OF EVIDENCE: II
- 1 July 2007
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 110 (1) , 81-86
Influence of an “Opt-Out” Test Strategy and Patient Factors on Human Immunodeficiency Virus Screening in Pregnancy
OBJECTIVE: To estimate both human immunodeficiency virus (HIV) testing acceptance rates in pregnancy using an opt-out policy and patient characteristics influencing acceptance. METHODS: At the first prenatal visit, HIV testing was offered using an opt-out approach. Reasons for refusing testing were explored. Demographic information was collected on all study subjects. RESULTS: In the prospective portion of the study, 1,140 of 1,233 women (92.5%) accepted testing. Race was predictive of accepting HIV testing, with Asian women significantly less likely (odds ratio [OR] 0.4; 95% confidence interval [CI] 0.3–0.6; P<.001) and Hispanic women significantly more likely (OR 6.9; 95% CI 2.2–22.0; P=.001) to be tested. Although English as a first language, country of birth, and insurance status were not significantly associated with acceptance, women who were fluent in English were more likely to be tested (OR 2.0; 95% CI 1.2–3.3; P=.01). Our testing rates were significantly higher than the provincial average. CONCLUSION: Using an opt-out strategy, HIV testing rates in our clinic were significantly higher than the provincial average. Rates were influenced by race and fluency in English. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov , www.clinicaltrials.gov , NCT00393302 LEVEL OF EVIDENCE: II
- 1 September 2005
- Published by Elsevier in Clinics in Perinatology
- Vol. 32 (3) , 617-627
Bacterial Vaginosis in Pregnancy: Diagnosis, Screening, and Management
- 1 September 2005
- Published by Elsevier in Clinics in Perinatology
- Vol. 32 (3) , 617-627
Bacterial Vaginosis in Pregnancy: Diagnosis, Screening, and Management
- 1 January 2005
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 105 (1) , 124-127
Severe Acute Respiratory Syndrome in Pregnancy
There is limited worldwide experience with severe acute respiratory syndrome (SARS) in pregnancy. We present a case of SARS complicating pregnancy in the third trimester, with outcome data on both the mother and baby. A 33-year-old gravida 2 para 1 fulfilling the World Health Organization case definition for probable SARS was admitted to our institution at 31 weeks of gestation with fever, a dry cough, and patchy infiltrates on chest X-ray. The patient was previously healthy and acquired SARS from close contact with an infected family member. Convalescent serology results were positive for antibodies to coronavirus. She stayed in hospital for 21 days and did not require intensive care admission or ventilatory support. Labor occurred spontaneously at term, and a healthy female baby was delivered with no evidence of infection. Severe acute respiratory syndrome in pregnancy is a potentially life-threatening illness with complicated management issues. Hospitalization and care by a multidisciplinary team may optimize chances for a good outcome.
- 1 January 2005
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 105 (1) , 124-127
Severe Acute Respiratory Syndrome in Pregnancy
There is limited worldwide experience with severe acute respiratory syndrome (SARS) in pregnancy. We present a case of SARS complicating pregnancy in the third trimester, with outcome data on both the mother and baby. A 33-year-old gravida 2 para 1 fulfilling the World Health Organization case definition for probable SARS was admitted to our institution at 31 weeks of gestation with fever, a dry cough, and patchy infiltrates on chest X-ray. The patient was previously healthy and acquired SARS from close contact with an infected family member. Convalescent serology results were positive for antibodies to coronavirus. She stayed in hospital for 21 days and did not require intensive care admission or ventilatory support. Labor occurred spontaneously at term, and a healthy female baby was delivered with no evidence of infection. Severe acute respiratory syndrome in pregnancy is a potentially life-threatening illness with complicated management issues. Hospitalization and care by a multidisciplinary team may optimize chances for a good outcome.